On 3 June 2026, Raily Aesthetic Medicine International Holdings Limited (RAILY AESMED) filed its monthly return for the period ended 31 May 2026, showing no changes in share capital structure.

The authorised share capital remained at 1 billion ordinary shares with a par value of USD 0.05, equivalent to USD 50.00 million.

Issued shares were unchanged at 557.08 million, and the company continued to hold no treasury shares. RAILY AESMED confirmed compliance with the Hong Kong Stock Exchange’s 25% public-float requirement.

Under the share-option scheme adopted on 4 December 2020, 47.28 million options were outstanding at month-end, representing a potential dilution of approximately 8.49% of the existing share base if fully exercised. No options were exercised, and no funds were raised during the month.

The filing indicated no warrants, convertible securities, or other equity arrangements, and the company secretary, Chan Oi Fat, affirmed full adherence to all applicable listing and regulatory requirements.